Table 5 Summary of experimental data on autophosphorylation of type B insulin receptor
From: Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
Samples | N = 1 | N = 2 | N = 3 | Mean ± SEM | P value | |
|---|---|---|---|---|---|---|
EC50 (nM) | EC50 (nM) | EC50 (nM) | vs S-Insulin | Lantus vs. Lisargine | ||
S-Insulin | 24.6 | 8.5 | 31.5 | 22.7 ± 4.6 | / | / |
Lantus | 17.6 | 6.6 | 21.8 | 16.0 ± 3.1 | 0.489 | / |
H-Insulin | 28.3 | 9.8 | 17.8 | 16.9 ± 2.8 | 0.752 | / |
Lisargine | 29.0 | 7.9 | 20.1 | 17.5 ± 3.4 | 0.796 | 0.653 |